A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
一项针对进展期激素难治性前列腺癌患者的索拉非尼II期临床研究：CESAR中欧抗癌药物研究学会-EWIV研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6604064
Steinbild, S; Mross, K; Frost, A; Morant, R; Gillessen, S; Dittrich, C; Strumberg, D; Hochhaus, A; Hanauske, A-R; Edler, L; Burkholder, I; Scheulen, M
